chemistry

Institute of Molecular Biotechnology

Institute of Molecular Biotechnology is a chemistry topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Institute of Molecular Biotechnology rather than just read about it. In short: The Institute of Molecular Biotechnology (IMBA) is a biomedical research organisation of the Austrian Academy of Sciences, founded in cooperation with the pharmaceutical company Boehringer Ingelheim. The institute employs around 250 people from over 40 countries, who perform basic research.

Institute of Molecular Biotechnology — illustration

Key takeaways

Institute of Molecular Biotechnology belongs to chemistry; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect Institute of Molecular Biotechnology to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of Institute of Molecular Biotechnology from memory before moving on to harder problems.

Reference excerpt

The Institute of Molecular Biotechnology (IMBA) is a biomedical research organisation of the Austrian Academy of Sciences, founded in cooperation with the pharmaceutical company Boehringer Ingelheim. The institute employs around 250 people from over 40 countries, who perform basic research. IMBA is located at the Vienna BioCenter and shares facilities and scientific training programs with the Gregor Mendel Institute of Molecular Plant Biology (GMI) of the Austrian Academy of Sciences and the Research Institute of Molecular Pathology (IMP), the basic research center of Boehringer Ingelheim.

Research

Research at IMBA aims to understand the fundamental molecular biological processes underlying the 3D architecture of genomes, the functions of small RNAs, and the in vitro reconstitution from stem cells of whole organs and embryos. As of 2026, the institute comprises 14 research groups:

Julius Brennecke: Transposon silencing & heterochromatin formation by small RNAs. Pioneer in the discovery of the piRNA/Piwi pathway. Alejandro Burga: Molecular determinants of biological idiosyncrasy. Daan de Groot: Single cell fate determination. Daniel Gerlich: Chromosome sturcutre and dynamics. Anton Goloborodko: Theoretical models of chromosome structure. Sofia Grade: Mechanisms of plasticity after brain injury. Joanna Jachowicz: Dark genome in early mammalian development. Jürgen Knoblich: Brain development and disease. Developer of the cerebral organoid. Sven Klumpe: In situ structural biology and transposable elements Sasha Mendjan: Molecular control of human cardiogenesis. Developer of the human cardiac organoid. Josef Penninger (guest group of Medical University of Vienna): Modeling human disease. Nicolas Rivron: Blastoid development and implantation. Developer of the blastoid, a complete embryo model. Kristina Stapornwongkul: Role of metabolism in cell fate determination Elly Tanaka: Molecular mechanisms of vertebrate regeneration. Noelia Urbán: Systemic regulation of adult neurogenesis.

Major scientific discoveries

2023: First multi-chamber heart organoids 2022: Disentanglement of the roles of condensin and histone deacetylation in chromosome assembly and chromatin compaction 2022: Identification of CLIP cells (human interneuron progenitors) as the origin of Tuberous Sclerosis using patient-derived cerebral organoids 2021: Human blastoids model blastocyst development and implantation 2021: Cardioids reveal self-organizing principles of human cardiogenesis 2020: Identification of a brain-size determinant using cerebral organoids 2020: Discovery on the conformation of sister chromatids in the replicated human genome 2019: Generation of blood vessel organoids from human pluripotent stem cells. 2017: Development of SLAM-Seq for the high-resolution assessment of RNA expression dynamics 2013: Generation of cerebral organoids from human pluripotent stem cells to model human brain development 2008: Discovery of an endogenous small interfering RNA pathway in Drosophila. 2005: Discovery of the role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury.

History

The institute was founded in 1999 as a joint initiative of the Austrian Academy of Sciences and Boehringer Ingelheim and with contributions from the Austrian Government and the city of Vienna. The construction of the building was initiated in 2003 and completed in 2006. It is linked to the building of the Research Institute of Molecular Pathology by a bridge so as to enhance collaborations. Both institutes share a common canteen and their scientific core facilities. In 2002, the geneticist Josef Penninger started as the Scientific Director of the IMBA and recruited Barry Dickson as the first group leader. In 2007 the Vienna Drosophila RNAi Center (VDRC) opened, in collaboration with the Research Institute of Molecular Pathology. In 2018, Josef Penninger was appointed as director of the Life Science Institute of the University of British Columbia and Jürgen Knoblich took the position as interim director of IMBA. In 2020, the institute expanded into an additional building of the Vienna Biocenter (termed VBC6). In 2024, Elly Tanaka took the position as Scientific Director of IMBA.

Scientific Advisory Board IMBA employs a process of review and feedback led by an external Scientific Advisory Board (SAB) of scientists. The board meets yearly and, together with group leaders, discusses the quality, significance, and focus of research conducted. As of 2026, the board is chaired by Maria Leptin (European Research Council), and includes Iain Cheeseman (Whitehead Institute and Massachusetts Institute of Technology), Déborah Bourc'his (Institut Curie), Denis Jabaudon (Geneva University), Elizabeth Robertson (Sir William Dunn School of Pathology, University of Oxford), Alexander van Oudenaarden (Hubrecht Institute).

Core scientific facilities Core scientific facilities within IMBA provide services to facilitate research making use of stem cells, flies/worms, informatics, optics, molecular biology, comparative medicine, transgenics, protein chemistry, or graphic designs. These core facilities are managed by technical leaders who evaluate and implement a wide range of novel technologies and instrumentations. These professional staff scientists also train users, help with experimental design, and disseminate expert knowledge. IMBA scientists are not billed for core services, except for certain experiment-related consumables. Beyond the core scientific facilities of the institute, IMBA laboratories are also financially supported to use of the core facilities of the Vienna Biocenter.

Seminar and conferences IMBA acts as a forum for academic exchange through its participation to a series of weekly internal Vienna Biocenter seminars, and

weekly guest lectures (termed "Vienna BioCenter lectures" and "Impromptus") from external, recognised or upcoming scientists. IMBA and the IMP co-organize the yearly SY-Stem symposium focusing on the next generation of stem cell researchers.

PhD program The Vienna Biocenter PhD Program is an international PhD training program carried out jointly by four of the Vienna Biocenter research institutes (IMP, IMBA, GMI and Max Perutz Labs). Acceptance into the program is competitive and based on a formal selection procedure. There are two selections each year, deadlines are usually on April 30 and November 15. Participation in the program is a condition for doing a PhD at IMBA.

… excerpt ends here. Continue reading the full article.

Illustrations

Worked examples

Example 1 — a first encounter with Institute of Molecular Biotechnology

Start with the simplest possible case. Write down what Institute of Molecular Biotechnology claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In chemistry, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Institute of Molecular Biotechnology before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Institute of Molecular Biotechnology ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Institute of Molecular Biotechnology

In research: Institute of Molecular Biotechnology appears in chemistry research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses Institute of Molecular Biotechnology in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: Institute of Molecular Biotechnology is common in secondary-school and first-year university syllabi. It links to neighbouring topics Biochemistry research institutes, Education in Vienna, Research institutes in Austria, so understanding it makes those chapters shorter.
In everyday life: Look for Institute of Molecular Biotechnology outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Institute of Molecular Biotechnology” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Institute of Molecular Biotechnology in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what Institute of Molecular Biotechnology means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain Institute of Molecular Biotechnology out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Institute of Molecular Biotechnology in simple terms?

Why does Institute of Molecular Biotechnology matter?

Because it connects several chemistry ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Institute of Molecular Biotechnology?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Institute of Molecular Biotechnology.